doxorubucin cysteinyl- aspartyl- cysteinyl- arginyl- glycyl- aspartyl- cycsteinyl- phenylalanyl- cysteine conjugate
targets blood vessels of some tumors
Also Known As:
dox-RGD-4C conjugate; doxorubicin-RGD-4C conjugate
Networked: 1
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
Related Drugs and Biologics